Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

Objective. Psoriatic arthritis (PsA) can be treated with biological drugs targeting IL-17A, such as secukinumab, with good responses and long-term positive outcomes in clinical studies. Methods. An observational study was conducted on adult subjects with PsA and comorbidities, treated with secuki...

Full description

Saved in:
Bibliographic Details
Main Authors: Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio
Format: Article
Language:English
Published: PAGEPress Publications 2025-01-01
Series:Reumatismo
Subjects:
Online Access:https://www.reumatismo.org/reuma/article/view/1694
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items